PT  - JOURNAL ARTICLE
AU  - Eric L Harshfield
AU  - Marios K Georgakis
AU  - Rainer Malik
AU  - Martin Dichgans
AU  - Hugh S Markus
TI  - Modifiable lifestyle factors and risk of stroke: a Mendelian randomization analysis
AID  - 10.1101/2020.03.17.20037549
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.17.20037549
4099  - http://medrxiv.org/content/early/2020/03/20/2020.03.17.20037549.short
4100  - http://medrxiv.org/content/early/2020/03/20/2020.03.17.20037549.full
AB  - Aims Assessing whether modifiable risk factors are causally associated with reduced stroke risk is important in planning public health measures, but determining causality can be difficult in epidemiological data. Leveraging large-scale genetic data in a technique known as Mendelian randomisation, we aimed to determine whether modifiable lifestyle factors including educational attainment, smoking, and body mass index are causal risk factors for ischaemic stroke and its different subtypes and haemorrhagic stroke.Methods and Results We performed two-sample and multivariable Mendelian randomization to assess the causal effect of twelve lifestyle factors on risk of stroke and whether these effects are independent. We found genetic predisposition to increased number of years of education to be inversely associated with ischaemic, large-artery, and small-vessel stroke, as well as with intracerebral haemorrhage. Genetic predisposition to ever smoking regularly, higher body mass index (BMI), and higher waist-hip ratio are also associated with ischaemic and large-artery stroke. Additionally, we found that the effects of education, BMI, and smoking on ischaemic stroke to be independent of each other.Conclusion Genetic predisposition to higher educational attainment can reduce the risk of ischaemic, large-artery, and small-vessel stroke, while genetic predisposition to smoking and higher anthropometry measures can increase the risk of these stroke subtypes. This suggests that lifestyle modification addressing these risk factors will reduce stroke risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the British Heart Foundation [RG/16/4/32218]; the European Union’s Horizon 2020 research and innovation programme [No 667375 (CoSTREAM) and No 666881 (SVDs@target)]; a grant for strategic collaboration between Ludwig-Maximilians-University Munich and the University of Cambridge; Cambridge University Hospitals National Institute for Health Research Biomedical Research Centre [*]; the Onassis Foundation [to M.K.G.]; the Deutsche Forschungsgemeinschaft [Munich Cluster for Systems Neurology (EXC 1010 SyNergy) and Collaborative Research Center 1123 (B3) to M.D.]; the Corona Foundation [to M.D.]; Fondation Leducq [Transatlantic Networks of Excellence Program on the Pathogenesis of Small Vessel Disease of the Brain to M.D.]; and the National Institute for Health Research [Senior Investigator Award to H.S.M.] [*]. The funding organisations had no role in any of the following: design and conduct of the study; collection, management, analysis, and interpretation of the data; review, or approval of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. [*] The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe GWAS summary statistics used to perform the analyses described in this study were obtained from publicly available published data. All data generated or analysed during this study are included in the manuscript and its supplementary materials. https://www.thessgac.org/data http://sleepdisordergenetics.org/informational/data https://data.bris.ac.uk/data/dataset/10i96zb8gm0j81yz0q6ztei23d https://conservancy.umn.edu/handle/11299/201564 https://digitalhub.northwestern.edu/collections/7badb7c9-d4ec-4ca9-b58e-6e01f224fcf7 https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files https://www.megastroke.org/ http://cerebrovascularportal.org/